137 related articles for article (PubMed ID: 25393675)
1. Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.
Budziszewska BK; Pluta A; Sulek K; Wierzbowska A; Robak T; Giebel S; Holowiecka-Goral A; Sawicki W; Ejduk A; Patkowska E; Manko J; Gajkowska-Kulik J; Piszcz J; Mordak-Domagala M; Madry K; Holowiecki J; Kyrcz-Krzemien S; Nowakowska-Domagala M; Dmoszynska A; Calbecka M; Kloczko J; Wiktor Jędrzejczak W; Lange A; Razny M; Bilinski P; Warzocha K; Lech-Maranda E
Leuk Lymphoma; 2015; 56(8):2331-8. PubMed ID: 25393675
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.
Yoon JH; Cho BS; Kim HJ; Kim JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Am J Hematol; 2013 Dec; 88(12):1074-81. PubMed ID: 23983148
[TBL] [Abstract][Full Text] [Related]
3. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
4. Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG.
Owattanapanich W; Utchariyaprasit E; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Limvorapitak W; Kanitsap N; Wanitpongpun C; Nakhakes C; Sriswasdi C; Prayongratana K
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e509-e514. PubMed ID: 30213720
[TBL] [Abstract][Full Text] [Related]
5. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
Tawfik B; Pardee TS; Isom S; Sliesoraitis S; Winter A; Lawrence J; Powell BL; Klepin HD
J Geriatr Oncol; 2016 Jan; 7(1):24-31. PubMed ID: 26527394
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
Liu H; Fu R; Li L; Wang G; Song J; Ruan E; Wang H; Wu Y; Wang X; Ding K; Shao Z
Clin Drug Investig; 2017 Feb; 37(2):167-174. PubMed ID: 27722823
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.
Etienne A; Esterni B; Charbonnier A; Mozziconacci MJ; Arnoulet C; Coso D; Puig B; Gastaut JA; Maraninchi D; Vey N
Cancer; 2007 Apr; 109(7):1376-83. PubMed ID: 17326052
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysis.
Mayer K; Serries M; Hahn-Ast C; Bisht S; Brossart P; Feldmann G
Hematology; 2023 Dec; 28(1):2212536. PubMed ID: 37204122
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia.
Dhakal P; Shostrom V; Al-Kadhimi ZS; Maness LJ; Gundabolu K; Bhatt VR
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):804-812.e8. PubMed ID: 32739312
[TBL] [Abstract][Full Text] [Related]
13. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
Maurillo L; Buccisano F; Spagnoli A; Voso MT; Fianchi L; Papayannidis C; Gaidano GL; Breccia M; Musto P; De Bellis E; Del Principe MI; Lunghi M; Lessi F; Martinelli G; Venditti A
Ann Hematol; 2018 Oct; 97(10):1767-1774. PubMed ID: 29947973
[TBL] [Abstract][Full Text] [Related]
17. Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia.
Wass M; Hitz F; Schaffrath J; Müller-Tidow C; Müller LP
PLoS One; 2016; 11(10):e0164587. PubMed ID: 27732646
[TBL] [Abstract][Full Text] [Related]
18. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study.
Tombak A; Uçar MA; Akdeniz A; Tiftik EN; Gören Şahin D; Akay OM; Yıldırım M; Nevruz O; Kis C; Gürkan E; Solmaz ŞM; Özcan MA; Yıldırım R; Berber İ; Erkurt MA; Fıratlı Tuğlular T; Tarkun P; Yavaşoğlu İ; Doğu MH; Sarı İ; Merter M; Özcan M; Yıldızhan E; Kaynar L; Mehtap Ö; Uysal A; Şahin F; Salim O; Sungur MA
Turk J Haematol; 2016 Dec; 33(4):273-280. PubMed ID: 27095141
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.
Heiblig M; Elhamri M; Le Jeune C; Laude MC; Deloire A; Wattel E; Salles G; Thomas X
Eur J Haematol; 2017 Feb; 98(2):134-141. PubMed ID: 27717105
[TBL] [Abstract][Full Text] [Related]
20. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
